2016 adult flu

Ended Definitive Contract Awarded Last action

Contract number
HHSD200201688480C
Awardee
Awarding agency
Obligated
$141,180

Award facts

Opportunity
  • 2016N17633 Solicitation number
Contract value 4% obligated
$3,620,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02139, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Supplemental Agreement for work within scope 1 $140,456
Original award $724

About this award

This is a $3,620,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Novartis Vaccines and Diagnostics, Inc. for the "2016 ADULT FLU" program. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2017. It is not a set-aside contract. This contract may be related to the CDC's efforts to provide vaccines and diagnostics for influenza preparedness and response, but additional details about the specific products or services being delivered are not provided.

Quick answers

Who was awarded contract HHSD200201688480C?

HHSD200201688480C was awarded to Novartis Vaccines And Diagnostics, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on December 18, 2015.

How much is contract HHSD200201688480C worth?

The government has obligated $141,180 on HHSD200201688480C. Its current value, with exercised options, is $3,620,000.

Was contract HHSD200201688480C competed?

The extent of competition for HHSD200201688480C was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award